A new pilot study is generating excitement with TH07, a triple-threat topical treatment combining Minoxidil, Finasteride, and ...

The A.A.O. recommends that adults with no signs or risk factors for eye disease get a comprehensive exam at 40 to establish a ...

Glaukos Corporation GKOS recently announced the commercial availability of Epioxa, marking a significant milestone in its corneal health portfolio. The therapy stands out as the first FDA-approved, ...

Australia is fortunate to have one of the most comprehensive eye health systems in the world, with optometrists playing a ...

A new class of beta blockers designed to activate only when struck by specific wavelengths of light could allow doctors to ...

Kensington, MD, USA and Munich/Martinsried, Germany, March 20, 2026 (GLOBE NEWSWIRE) --Prodrug of oral amyloid beta aggregation modulator demonstrated improved absorption characte ...

A 2026 company-issued report outlining Retina Clear's 'Red Root Hack' marketing narrative, ingredient research context, ...

Currently, motorists are not subjected to obligatory checks of their skills or health once they obtain their licence ...

Commercial rollout includes direct purchasing and specialty distribution, alongside scaled investments in awareness, education, screening, and diagnosis to drive earlier keratoconus detection. Epioxa ...

ChemR23 agonism targets inflammatory and neurosensory biology, with receptor expression on ocular immune cells and dorsal root ganglion neurons/glia supporting a mechanistic rationale for NCP symptom ...

The approval and availability of Epioxa, a noninvasive, epithelium-on, oxygen-enriched treatment for keratoconus represents a significant advancement in patient care. Not only does Epioxa provide a ...

The medical landscape undergoes a rapid transformation as precision becomes the standard of care. At the heart of this ...